Chemed Corp Net Worth
Chemed Corp Net Worth Breakdown | CHE |
Chemed Corp Net Worth Analysis
Chemed Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Chemed Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Chemed Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Chemed Corp's net worth analysis. One common approach is to calculate Chemed Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Chemed Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Chemed Corp's net worth. This approach calculates the present value of Chemed Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Chemed Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Chemed Corp's net worth. This involves comparing Chemed Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Chemed Corp's net worth relative to its peers.
Enterprise Value |
|
To determine if Chemed Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chemed Corp's net worth research are outlined below:
| Chemed Corp is unlikely to experience financial distress in the next 2 years | |
| Chemed Corp has 140.84 M in debt with debt to equity (D/E) ratio of 0.38, which is OK given its current industry classification. Chemed Corp has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Chemed to invest in growth at high rates of return. | |
| Over 97.0% of Chemed Corp shares are held by institutions such as insurance companies | |
| On 14th of March 2025 Chemed Corp paid $ 0.5 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Senior Health, Home Health Hospice Stocks Q4 Teardown AdaptHealth Vs The Rest |
Chemed Corp Quarterly Good Will |
|
Chemed Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chemed Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chemed Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Chemed Corp Target Price Consensus
Chemed target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Chemed Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Chemed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Chemed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Chemed Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationChemed Corp Target Price Projection
Chemed Corp's current and average target prices are 598.22 and 663.67, respectively. The current price of Chemed Corp is the price at which Chemed Corp is currently trading. On the other hand, Chemed Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Chemed Corp Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Chemed Corp Target Price
Know Chemed Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chemed Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemed Corp backward and forwards among themselves. Chemed Corp's institutional investor refers to the entity that pools money to purchase Chemed Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-12-31 | 266.8 K | Td Global Investment Solutions – Td Epoch | 2024-12-31 | 252.2 K | Btim Corp | 2024-12-31 | 242.2 K | Ameriprise Financial Inc | 2024-12-31 | 233.7 K | Northern Trust Corp | 2024-12-31 | 208.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 199.3 K | Amvescap Plc. | 2024-12-31 | 182.1 K | Norges Bank | 2024-12-31 | 181 K | Dekabank Deutsche Girozentrale | 2024-12-31 | 155.3 K | Vanguard Group Inc | 2024-12-31 | 1.7 M | Blackrock Inc | 2024-12-31 | 1.4 M |
Follow Chemed Corp's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 8.64 B.Market Cap |
|
Project Chemed Corp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.33 | 0.35 | |
| Return On Capital Employed | 0.27 | 0.14 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 7.62 | 8.00 |
When accessing Chemed Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Chemed Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chemed Corp's profitability and make more informed investment decisions.
Please note, the presentation of Chemed Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemed Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemed Corp's management manipulating its earnings.
Evaluate Chemed Corp's management efficiency
Chemed Corp has Return on Asset of 0.1395 % which means that on every $100 spent on assets, it made $0.1395 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2712 %, implying that it generated $0.2712 on every 100 dollars invested. Chemed Corp's management efficiency ratios could be used to measure how well Chemed Corp manages its routine affairs as well as how well it operates its assets and liabilities. At present, Chemed Corp's Return On Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 8.00, whereas Return On Capital Employed is forecasted to decline to 0.14. At present, Chemed Corp's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 196.1 M, whereas Total Current Assets are forecasted to decline to about 198.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 74.48 | 78.20 | |
| Tangible Book Value Per Share | 23.96 | 25.16 | |
| Enterprise Value Over EBITDA | 17.06 | 9.90 | |
| Price Book Value Ratio | 200.77 | 210.81 | |
| Enterprise Value Multiple | 17.06 | 9.90 | |
| Price Fair Value | 200.77 | 210.81 | |
| Enterprise Value | 7.1 B | 7.5 B |
Examining the leadership quality of Chemed Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 3.5319 | Revenue | Quarterly Revenue Growth 0.092 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemed Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemed Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemed Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chemed Corp Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 20th of December 2024 Other Reports | ViewVerify |
Chemed Corp Earnings Estimation Breakdown
The calculation of Chemed Corp's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Chemed Corp is estimated to be 5.595 with the future projection ranging from a low of 5.56 to a high of 5.63. Please be aware that this consensus of annual earnings estimates for Chemed Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
5.56 Lowest | Expected EPS | 5.63 Highest |
Chemed Corp Earnings Projection Consensus
Suppose the current estimates of Chemed Corp's value are higher than the current market price of the Chemed Corp stock. In this case, investors may conclude that Chemed Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Chemed Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 3 | 96.71% | 6.83 | 5.595 | 19.92 |
Chemed Corp Earnings History
Earnings estimate consensus by Chemed Corp analysts from Wall Street is used by the market to judge Chemed Corp's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Chemed Corp's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Chemed Corp Quarterly Gross Profit |
|
Chemed Corp Earnings per Share Projection vs Actual
Actual Earning per Share of Chemed Corp refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Chemed Corp predict the company's earnings will be in the future. The higher the earnings per share of Chemed Corp, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Chemed Corp Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Chemed Corp, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Chemed Corp should always be considered in relation to other companies to make a more educated investment decision.Chemed Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Chemed Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-25 | 2024-12-31 | 6.79 | 6.83 | 0.04 | 0 | ||
2024-10-29 | 2024-09-30 | 5.76 | 5.64 | -0.12 | 2 | ||
2024-07-24 | 2024-06-30 | 5.59 | 5.47 | -0.12 | 2 | ||
2024-04-24 | 2024-03-31 | 5.48 | 5.2 | -0.28 | 5 | ||
2024-02-27 | 2023-12-31 | 6.25 | 6.6 | 0.35 | 5 | ||
2023-10-25 | 2023-09-30 | 4.9 | 5.32 | 0.42 | 8 | ||
2023-07-26 | 2023-06-30 | 5.09 | 4.71 | -0.38 | 7 | ||
2023-04-26 | 2023-03-31 | 4.81 | 4.82 | 0.01 | 0 | ||
2023-02-23 | 2022-12-31 | 5.32 | 5.39 | 0.07 | 1 | ||
2022-10-31 | 2022-09-30 | 4.65 | 4.74 | 0.09 | 1 | ||
2022-07-27 | 2022-06-30 | 4.78 | 4.84 | 0.06 | 1 | ||
2022-04-26 | 2022-03-31 | 4.47 | 4.79 | 0.32 | 7 | ||
2022-02-24 | 2021-12-31 | 5.08 | 5.25 | 0.17 | 3 | ||
2021-10-28 | 2021-09-30 | 4.49 | 5.06 | 0.57 | 12 | ||
2021-07-27 | 2021-06-30 | 4.29 | 4.6 | 0.31 | 7 | ||
2021-04-27 | 2021-03-31 | 4.02 | 4.44 | 0.42 | 10 | ||
2021-02-23 | 2020-12-31 | 5.13 | 5.13 | 0.0 | 0 | ||
2020-10-29 | 2020-09-30 | 3.97 | 4.86 | 0.89 | 22 | ||
2020-07-29 | 2020-06-30 | 3.75 | 4.41 | 0.66 | 17 | ||
2020-04-28 | 2020-03-31 | 3.65 | 3.68 | 0.03 | 0 | ||
2020-02-18 | 2019-12-31 | 4.09 | 4.22 | 0.13 | 3 | ||
2019-10-30 | 2019-09-30 | 3.31 | 3.46 | 0.15 | 4 | ||
2019-07-25 | 2019-06-30 | 3.12 | 3.36 | 0.24 | 7 | ||
2019-04-29 | 2019-03-31 | 2.96 | 2.92 | -0.04 | 1 | ||
2019-02-20 | 2018-12-31 | 3.26 | 3.35 | 0.09 | 2 | ||
2018-10-29 | 2018-09-30 | 2.8 | 3.07 | 0.27 | 9 | ||
2018-07-25 | 2018-06-30 | 2.77 | 2.81 | 0.04 | 1 | ||
2018-04-19 | 2018-03-31 | 2.36 | 2.72 | 0.36 | 15 | ||
2018-02-14 | 2017-12-31 | 2.27 | 2.32 | 0.05 | 2 | ||
2017-10-26 | 2017-09-30 | 2.01 | 2.15 | 0.14 | 6 | ||
2017-07-25 | 2017-06-30 | 1.89 | 2.15 | 0.26 | 13 | ||
2017-04-26 | 2017-03-31 | 1.79 | 1.82 | 0.03 | 1 | ||
2017-02-15 | 2016-12-31 | 2.1 | 2.1 | 0.0 | 0 | ||
2016-10-26 | 2016-09-30 | 1.82 | 1.77 | -0.05 | 2 | ||
2016-07-25 | 2016-06-30 | 1.72 | 1.8 | 0.08 | 4 | ||
2016-04-28 | 2016-03-31 | 1.58 | 1.62 | 0.04 | 2 | ||
2016-02-17 | 2015-12-31 | 1.81 | 1.97 | 0.16 | 8 | ||
2015-10-22 | 2015-09-30 | 1.61 | 1.78 | 0.17 | 10 | ||
2015-07-23 | 2015-06-30 | 1.59 | 1.71 | 0.12 | 7 | ||
2015-04-28 | 2015-03-31 | 1.44 | 1.54 | 0.1 | 6 | ||
2015-02-17 | 2014-12-31 | 1.69 | 1.8 | 0.11 | 6 | ||
2014-10-30 | 2014-09-30 | 1.51 | 1.48 | -0.03 | 1 | ||
2014-07-23 | 2014-06-30 | 1.47 | 1.5 | 0.03 | 2 | ||
2014-04-29 | 2014-03-31 | 1.32 | 1.32 | 0.0 | 0 | ||
2014-02-17 | 2013-12-31 | 1.46 | 1.45 | -0.01 | 0 | ||
2013-10-28 | 2013-09-30 | 1.34 | 1.36 | 0.02 | 1 | ||
2013-07-18 | 2013-06-30 | 1.33 | 1.44 | 0.11 | 8 | ||
2013-04-18 | 2013-03-31 | 1.29 | 1.38 | 0.09 | 6 | ||
2013-02-18 | 2012-12-31 | 1.48 | 1.57 | 0.09 | 6 | ||
2012-10-29 | 2012-09-30 | 1.35 | 1.28 | -0.07 | 5 | ||
2012-07-25 | 2012-06-30 | 1.26 | 1.26 | 0.0 | 0 | ||
2012-04-19 | 2012-03-31 | 1.28 | 1.21 | -0.07 | 5 | ||
2012-02-14 | 2011-12-31 | 1.48 | 1.45 | -0.03 | 2 | ||
2011-10-25 | 2011-09-30 | 1.1 | 1.04 | -0.06 | 5 | ||
2011-07-26 | 2011-06-30 | 1.1 | 0.94 | -0.16 | 14 | ||
2011-04-25 | 2011-03-31 | 0.98 | 0.84 | -0.14 | 14 | ||
2011-02-15 | 2010-12-31 | 1.05 | 0.98 | -0.07 | 6 | ||
2010-10-25 | 2010-09-30 | 0.92 | 0.91 | -0.01 | 1 | ||
2010-07-28 | 2010-06-30 | 0.9 | 0.82 | -0.08 | 8 | ||
2010-04-20 | 2010-03-31 | 0.87 | 0.84 | -0.03 | 3 | ||
2010-02-15 | 2009-12-31 | 0.94 | 0.78 | -0.16 | 17 | ||
2009-10-27 | 2009-09-30 | 0.88 | 0.84 | -0.04 | 4 | ||
2009-07-30 | 2009-06-30 | 0.8 | 0.77 | -0.03 | 3 | ||
2009-04-22 | 2009-03-31 | 0.83 | 0.85 | 0.02 | 2 | ||
2009-02-16 | 2008-12-31 | 0.92 | 0.84 | -0.08 | 8 | ||
2008-10-21 | 2008-09-30 | 0.75 | 0.79 | 0.04 | 5 | ||
2008-07-28 | 2008-06-30 | 0.69 | 0.73 | 0.04 | 5 | ||
2008-04-24 | 2008-03-31 | 0.83 | 0.69 | -0.14 | 16 | ||
2008-02-21 | 2007-12-31 | 0.88 | 0.88 | 0.0 | 0 | ||
2007-10-30 | 2007-09-30 | 0.78 | 0.7 | -0.08 | 10 | ||
2007-08-01 | 2007-06-30 | 0.73 | 0.77 | 0.04 | 5 | ||
2007-04-30 | 2007-03-31 | 0.55 | 0.71 | 0.16 | 29 | ||
2007-02-20 | 2006-12-31 | 0.57 | 0.73 | 0.16 | 28 | ||
2006-10-26 | 2006-09-30 | 0.47 | 0.48 | 0.01 | 2 | ||
2006-07-25 | 2006-06-30 | 0.49 | 0.49 | 0.0 | 0 | ||
2006-04-25 | 2006-03-31 | 0.52 | 0.47 | -0.05 | 9 | ||
2006-02-21 | 2005-12-31 | 0.55 | 0.61 | 0.06 | 10 | ||
2005-10-27 | 2005-09-30 | 0.46 | 0.49 | 0.03 | 6 | ||
2005-08-03 | 2005-06-30 | 0.43 | 0.45 | 0.02 | 4 | ||
2005-05-03 | 2005-03-31 | 0.35 | 0.4 | 0.05 | 14 | ||
2005-03-08 | 2004-12-31 | 0.37 | 0.41 | 0.04 | 10 | ||
2004-10-25 | 2004-09-30 | 0.3 | 0.32 | 0.02 | 6 | ||
2004-08-03 | 2004-06-30 | 0.26 | 0.33 | 0.07 | 26 | ||
2004-05-04 | 2004-03-31 | 0.2 | 0.23 | 0.03 | 15 | ||
2004-02-05 | 2003-12-31 | 0.12 | 0.06 | -0.06 | 50 | ||
2003-10-16 | 2003-09-30 | 0.14 | 0.1 | -0.04 | 28 | ||
2003-07-17 | 2003-06-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2003-02-07 | 2002-12-31 | 0.15 | 0.13 | -0.02 | 13 | ||
2000-04-20 | 2000-03-31 | 0.22 | 0.24 | 0.02 | 9 | ||
2000-02-04 | 1999-12-31 | 0.23 | 0.23 | 0.0 | 0 | ||
1999-10-20 | 1999-09-30 | 0.22 | 0.21 | -0.01 | 4 | ||
1999-07-21 | 1999-06-30 | 0.2 | 0.2 | 0.0 | 0 | ||
1998-02-05 | 1997-12-31 | 0.59 | 0.19 | -0.4 | 67 | ||
1997-10-20 | 1997-09-30 | 0.33 | 0.59 | 0.26 | 78 | ||
1997-07-17 | 1997-06-30 | 0.25 | 0.19 | -0.06 | 24 | ||
1997-04-17 | 1997-03-31 | 0.25 | 0.14 | -0.11 | 44 | ||
1997-02-06 | 1996-12-31 | 0.25 | 0.16 | -0.09 | 36 | ||
1996-10-17 | 1996-09-30 | 0.3 | 0.2 | -0.1 | 33 | ||
1996-07-18 | 1996-06-30 | 0.25 | 0.29 | 0.04 | 16 | ||
1996-04-18 | 1996-03-31 | 0.31 | 0.17 | -0.14 | 45 | ||
1996-02-05 | 1995-12-31 | 0.3 | 0.21 | -0.09 | 30 | ||
1995-10-19 | 1995-09-30 | 0.28 | 0.22 | -0.06 | 21 | ||
1995-04-20 | 1995-03-31 | 0.33 | 0.28 | -0.05 | 15 | ||
1995-02-02 | 1994-12-31 | 0.27 | 0.18 | -0.09 | 33 | ||
1994-10-21 | 1994-09-30 | 0.25 | 0.26 | 0.01 | 4 | ||
1994-07-21 | 1994-06-30 | 0.3 | 0.29 | -0.01 | 3 | ||
1994-04-21 | 1994-03-31 | 0.25 | 0.3 | 0.05 | 20 | ||
1994-02-04 | 1993-12-31 | 0.2 | 0.19 | -0.01 | 5 | ||
1993-10-22 | 1993-09-30 | 0.19 | 0.22 | 0.03 | 15 | ||
1993-07-20 | 1993-06-30 | 0.19 | 0.25 | 0.06 | 31 | ||
1993-04-22 | 1993-03-31 | 0.24 | 0.21 | -0.03 | 12 |
Chemed Corp Corporate Directors
| Andrea Lindell | Independent Director | Profile | |
| Thomas Rice | Independent Director | Profile | |
| Joel Gemunder | Independent Director | Profile | |
| Patrick Grace | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.021 | Dividend Share 1.8 | Earnings Share 19.92 | Revenue Per Share | Quarterly Revenue Growth 0.092 |
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.